These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 8276690)

  • 81. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ
    Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract]   [Full Text] [Related]  

  • 82. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 83. FDA establishes tolerances for tetracyclines in milk.
    J Am Vet Med Assoc; 1998 Oct; 213(7):946. PubMed ID: 9841236
    [No Abstract]   [Full Text] [Related]  

  • 84. New FDA rule affects drug labeling.
    J Am Vet Med Assoc; 1998 Sep; 213(5):598. PubMed ID: 9731244
    [No Abstract]   [Full Text] [Related]  

  • 85. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 86. FDA reaffirms position on extra-label use of ionophore drugs.
    J Am Vet Med Assoc; 1995 Oct; 207(7):828. PubMed ID: 7558998
    [No Abstract]   [Full Text] [Related]  

  • 87. Concerned about unlicensed practice.
    Allen JM
    J Am Vet Med Assoc; 1991 Sep; 199(6):679. PubMed ID: 1955352
    [No Abstract]   [Full Text] [Related]  

  • 88. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Restrictions on antibiotics proposed by the FDA: a practitioner's point of view.
    Blohm WD
    Vet Med Small Anim Clin; 1978 May; 73(5):558, 560, 562, passim. PubMed ID: 249153
    [No Abstract]   [Full Text] [Related]  

  • 90. FDA, off-label use, and informed consent: debunking myths and misconceptions.
    Beck JM; Azari ED
    Food Drug Law J; 1998; 53(1):71-104. PubMed ID: 11795338
    [No Abstract]   [Full Text] [Related]  

  • 91. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Plans to restrict 'extra-label' use of cephalosporins in the USA.
    Vet Rec; 2012 Feb; 170(6):142. PubMed ID: 22331777
    [No Abstract]   [Full Text] [Related]  

  • 94. Compounding for veterinarians by pharmacists.
    Lust EB
    J Am Vet Med Assoc; 1994 Jul; 205(2):261-3. PubMed ID: 7928594
    [No Abstract]   [Full Text] [Related]  

  • 95. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
    [TBL] [Abstract][Full Text] [Related]  

  • 96. FDA in hot water again over cost of proposed drug labeling rule.
    Demkovich LE
    Natl J (Wash); 1979 Sep; 11(38):1568-70. PubMed ID: 10243426
    [No Abstract]   [Full Text] [Related]  

  • 97. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
    Fed Regist; 1999 Aug; 64(158):44653-8. PubMed ID: 10558603
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pharmaceutical provisions of the FDA Modernization Act of 1997: one year and counting.
    Binder GM
    Curr Opin Biotechnol; 1999 Jun; 10(3):303-6. PubMed ID: 10361077
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Impact of the Animal Drug Availability Act on veterinary practitioners and the animal health industry.
    Troutman LM; Vaughn SD; Schmerfeld G; Beaulieu AJ
    J Am Vet Med Assoc; 1997 Jun; 210(11):1597-600. PubMed ID: 9170084
    [No Abstract]   [Full Text] [Related]  

  • 100. Evaluation of efficacy of heartworm preventive products at the FDA.
    Hampshire VA
    Vet Parasitol; 2005 Oct; 133(2-3):191-5. PubMed ID: 16099105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.